amyloid-beta-SM（Icb International Inc）
N/A
Report date: 2022/09/06 14:24:10
Base Information
Drug Nameamyloid-beta-SM（Icb International Inc）
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIcb International Inc
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A